Coffee Consumption and Risk of Myocardial Infarction: a Dose-response Meta-analysis of Observational Studies

Overview

Journal Oncotarget

Specialty Oncology

Date 2018 May 17

PMID 29765557

Citations 6

Authors

Long Mo

Wei Xie

Xiaoqun Pu

Dongsheng Ouyang

Affiliations

Soon will be listed here.

Abstract

Background: Previous epidemiological studies have provided inconsistent conclusions on the effect of coffee consumption in the development of myocardial infarction (MI). The aim of the study was to evaluate the influence of coffee consumption and its potential dose-response patterns on the risk of developing MI.

Materials And Methods: Three databases were searched for evidence of eligible studies. A random-effects model was used to pool the fully adjusted odds ratios (ORs) and the corresponding 95% confidence intervals (CIs). Dose-response analysis was performed to show the effect of each cup increased in daily coffee drinking on the risk of MI.

Results: Seventeen studies involving 233,617 participants were included in our study. The association between coffee consumption and risk of MI did not show statistical significance when pooling the outcome data for the coffee consumption categories of 1~2 vs. < 1 cup per day (OR = 1.06, 95% CI: 0.94-1.19) and 2~3 vs. < 1 cup per day (OR = 1.07, 95% CI: 0.94-1.23). Compared with < 1 cup, daily drinking of 3~4 cups and > 4 cups of coffee were significantly associated with the risk of MI, and the pooled ORs (95% CIs) were 1.40 (1.11-1.77) and 1.48 (1.22-1.79), respectively. The dose-response analysis showed a "J-shaped" curve relationship of the risk of MI with coffee consumption.

Conclusions: Daily drinking of more than three cups of coffee was associated with a significantly increased risk of MI. This positive association was only found in men but not in women. The impact of gender on this association should be further evaluated.

Citing Articles

Tea and coffee consumption and the 15-Year risk of cardiovascular events: the Isfahan cohort study (ICS).

Amani-Beni R, Sadeghi M, Nouri F, Darouei B, Mohammadifard N, Boshtam M Nutr J. 2025; 24(1):30.

PMID: 40001172 PMC: 11853883. DOI: 10.1186/s12937-025-01093-w.

An umbrella review of meta-analysis to understand the effect of coffee consumption and the relationship between stroke, cardiovascular heart disease, and dementia among its global users.

Gill H, Patel N, Naik N, Vala L, Rana R, Jain S J Family Med Prim Care. 2024; 13(11):4783-4796.

PMID: 39723018 PMC: 11668367. DOI: 10.4103/jfmpc.jfmpc_654_24.

Coffee consumption and adverse cardiovascular events in patients with atrial fibrillation.

Iten V, Herber E, Coslovsky M, Hennings E, Paladini R, Reichlin T BMC Med. 2024; 22(1):593.

PMID: 39696255 PMC: 11657746. DOI: 10.1186/s12916-024-03817-x.

Coffee consumption and cardiometabolic health: a comprehensive review of the evidence.

Ungvari Z, Kunutsor S Geroscience. 2024; 46(6):6473-6510.

PMID: 38963648 PMC: 11493900. DOI: 10.1007/s11357-024-01262-5.

Adverse Cardiovascular Events Associated With Kopi Jantan.

Othman M, Yusof Z, Mohd Rossli N, Mohd Fauzi M, W Isa W Cureus. 2024; 16(1):e52344.

PMID: 38361715 PMC: 10867548. DOI: 10.7759/cureus.52344.

References

Tavani A, Bertuzzi M, Negri E, Sorbara L, La Vecchia C . Alcohol, smoking, coffee and risk of non-fatal acute myocardial infarction in Italy. Eur J Epidemiol. 2003; 17(12):1131-7. DOI: 10.1023/a:1021276932160. View

Panagiotakos D, Pitsavos C, Chrysohoou C, Kokkinos P, Toutouzas P, Stefanadis C . The J-shaped effect of coffee consumption on the risk of developing acute coronary syndromes: the CARDIO2000 case-control study. J Nutr. 2003; 133(10):3228-32. DOI: 10.1093/jn/133.10.3228. View

Rosengren A, Wilhelmsen L . Coffee, coronary heart disease and mortality in middle-aged Swedish men: findings from the Primary Prevention Study. J Intern Med. 1991; 230(1):67-71. DOI: 10.1111/j.1365-2796.1991.tb00407.x. View

de Bree A, Verschuren W, Blom H, Kromhout D . Lifestyle factors and plasma homocysteine concentrations in a general population sample. Am J Epidemiol. 2001; 154(2):150-4. DOI: 10.1093/aje/154.2.150. View

Cornelis M, El-Sohemy A, Kabagambe E, Campos H . Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA. 2006; 295(10):1135-41. DOI: 10.1001/jama.295.10.1135. View

Li X, Xu L, Lin G, Li X, Jiang X, Wang T . Protective effect of caffeine administration on myocardial ischemia/reperfusion injury in rats. Shock. 2011; 36(3):289-94. DOI: 10.1097/SHK.0b013e3182222915. View

Begg C, Mazumdar M . Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50(4):1088-101. View

Mostofsky E, Schlaug G, Mukamal K, Rosamond W, Mittleman M . Coffee and acute ischemic stroke onset: the Stroke Onset Study. Neurology. 2010; 75(18):1583-8. PMC: 3120108. DOI: 10.1212/WNL.0b013e3181fb443d. View

Shryock J, Belardinelli L . Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol. 1997; 79(12A):2-10. DOI: 10.1016/s0002-9149(97)00256-7. View

10.

Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D . Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol. 2011; 175(1):66-73. PMC: 3244608. DOI: 10.1093/aje/kwr265. View

11.

Baylin A, Hernandez-Diaz S, Kabagambe E, Siles X, Campos H . Transient exposure to coffee as a trigger of a first nonfatal myocardial infarction. Epidemiology. 2006; 17(5):506-11. DOI: 10.1097/01.ede.0000229444.55718.96. View

12.

Fisone G, Borgkvist A, Usiello A . Caffeine as a psychomotor stimulant: mechanism of action. Cell Mol Life Sci. 2004; 61(7-8):857-72. PMC: 11138593. DOI: 10.1007/s00018-003-3269-3. View

13.

Tavani A, Bertuzzi M, Gallus S, Negri E, La Vecchia C . Risk factors for non-fatal acute myocardial infarction in Italian women. Prev Med. 2004; 39(1):128-34. DOI: 10.1016/j.ypmed.2004.01.010. View

14.

OKeefe J, Bhatti S, Patil H, DiNicolantonio J, Lucan S, Lavie C . Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol. 2013; 62(12):1043-1051. DOI: 10.1016/j.jacc.2013.06.035. View

15.

Smits P, Boekema P, de Abreu R, Thien T, Van t Laar A . Evidence for an antagonism between caffeine and adenosine in the human cardiovascular system. J Cardiovasc Pharmacol. 1987; 10(2):136-43. DOI: 10.1097/00005344-198708000-00002. View

16.

DAvanzo B, La Vecchia C, Tognoni G, Franceschi S, Franzosi M, Nobili A . Coffee consumption and risk of acute myocardial infarction in Italian males. GISSI-EFRIM. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto, Epidemiologia dei Fattori di Rischio del'Infarto Miocardico. Ann Epidemiol. 1993; 3(6):595-604. View

17.

Cano-Marquina A, Tarin J, Cano A . The impact of coffee on health. Maturitas. 2013; 75(1):7-21. DOI: 10.1016/j.maturitas.2013.02.002. View

18.

Lopez-Garcia E, van Dam R, Willett W, Rimm E, Manson J, Stampfer M . Coffee consumption and coronary heart disease in men and women: a prospective cohort study. Circulation. 2006; 113(17):2045-53. DOI: 10.1161/CIRCULATIONAHA.105.598664. View

19.

Grubben M, Boers G, Blom H, Broekhuizen R, de Jong R, Van Rijt L . Unfiltered coffee increases plasma homocysteine concentrations in healthy volunteers: a randomized trial. Am J Clin Nutr. 2000; 71(2):480-4. DOI: 10.1093/ajcn/71.2.480. View

20.

Rautiainen S, Levitan E, Orsini N, Akesson A, Morgenstern R, Mittleman M . Total antioxidant capacity from diet and risk of myocardial infarction: a prospective cohort of women. Am J Med. 2012; 125(10):974-80. DOI: 10.1016/j.amjmed.2012.03.008. View